Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

MLA

Hanarz, Maksymilian, et al. “Gender-Related and PUFA-Related Differences in Lipoprotein-Associated Phospholipase A2 Levels in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.” Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University, vol. 33, no. 6, June 2024, pp. 593–600. EBSCOhost, https://doi.org/10.17219/acem/171002.

APA

Hanarz, M., Siniarski, A., Gołębiowska-Wiatrak, R., Nessler, J., Malinowski, K. P., & Gajos, G. (2024). Gender-related and PUFA-related differences in lipoprotein-associated phospholipase A2 levels in patients with type 2 diabetes and atherosclerotic cardiovascular disease. Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University, 33(6), 593–600. https://doi.org/10.17219/acem/171002

Chicago

Hanarz, Maksymilian, Aleksander Siniarski, Renata Gołębiowska-Wiatrak, Jadwiga Nessler, Krzysztof Piotr Malinowski, and Grzegorz Gajos. 2024. “Gender-Related and PUFA-Related Differences in Lipoprotein-Associated Phospholipase A2 Levels in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.” Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University 33 (6): 593–600. doi:10.17219/acem/171002.